Marshall–Smith syndrome
(Redirected from Marshall-Smith syndrome)
Marshall–Smith syndrome (MSS) is a rare genetic disorder characterized by accelerated skeletal maturation, distinctive facial features, and developmental delays. The syndrome was first described by Marshall and Smith in 1971.
Signs and Symptoms[edit | edit source]
Individuals with Marshall–Smith syndrome typically present with a range of clinical features, including:
- Accelerated skeletal maturation
- Distinctive facial features such as a prominent forehead, large eyes, and a small nose
- Respiratory difficulties
- Developmental delays and intellectual disability
- Hypertrichosis (excessive hair growth)
- Failure to thrive
Genetics[edit | edit source]
Marshall–Smith syndrome is caused by mutations in the NFIX gene, which plays a crucial role in the development of the brain and bones. The condition is inherited in an autosomal dominant manner, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit | edit source]
Diagnosis of Marshall–Smith syndrome is based on clinical evaluation, identification of characteristic physical features, and genetic testing to confirm mutations in the NFIX gene. Radiographic imaging may also be used to assess skeletal abnormalities.
Management[edit | edit source]
There is no cure for Marshall–Smith syndrome, and treatment is primarily supportive and symptomatic. Management may include:
- Respiratory support for breathing difficulties
- Nutritional support to address failure to thrive
- Physical therapy and occupational therapy to aid in developmental progress
- Regular monitoring and management of associated health issues
Prognosis[edit | edit source]
The prognosis for individuals with Marshall–Smith syndrome varies depending on the severity of symptoms and associated complications. Early intervention and supportive care can improve the quality of life for affected individuals.
Related Pages[edit | edit source]
- Genetic disorder
- Developmental delay
- Intellectual disability
- Hypertrichosis
- Autosomal dominant inheritance
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD